2025-2026 Regular SessionMaine Legislature

LD1100

Legislative Summary

An Act to Clarify the Requirements for Accessing Nonformulary Drugs and Drugs Used to Treat Serious Mental Illness

Demographic Impact

Overall analysis of equity impact

70% Positive
Medium ConfidenceView detailed demographic breakdown ↓

Unlock Full Demographic Insights

Go beyond the overall score.

Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.

Enable full analysis features for your organization.

Contact Sales to Learn More

Or email us directly at sales@legiequity.us.

Bill History

3/14/2025
Received by the Secretary of the Senate on March 14, 2025 and REFERRED to the Committee on HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES pursuant to Joint Rule 308.2
Senate
3/21/2025
CARRIED OVER, in the same posture, to the next special or regular session of the 132nd Legislature, pursuant to Joint Order SP 519.
Senate
4/9/2025
Work Session Held
Joint Conference
4/9/2025
Voted: OTP-AM
Joint Conference

Status Information

Current Status
Introduced(3/14/2025)
Chamber
Joint Conference
Committee
Health Coverage, Insurance and Financial Services(Joint Conference)

Sponsors

Democrat: 1

Primary Sponsor

Donna Bailey
Donna Bailey
Democrat

Documents

Introduced
Bill Text1/1/1970169.9 KB